Company
Headquarters: Berlin, Germany
Employees: 300
CEO: Mr. Matthias Gaertner
€328.0 Million
EUR as of Jan. 1, 2025
US$341.3 Million
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.80 B |
Cencora, Inc. | $47.92 B |
Cardinal Health, Inc. | $31.29 B |
Henry Schein, Inc. | $9.32 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures drugs for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Medios AG has the following listings and related stock indices.
Stock: FSX: ILM1 wb_incandescent
Stock: XDUS: ILM1 wb_incandescent
Stock: XETR: ILM1 wb_incandescent